ALZHEIMERS DISEASE, FAMILIAL
Clinical trials for ALZHEIMERS DISEASE, FAMILIAL explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE, FAMILIAL trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, FAMILIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug delay Alzheimer's in High-Risk families?
Disease control OngoingThis study tests whether certain drugs can slow memory loss and thinking problems in people who have a genetic mutation that causes Alzheimer's disease. About 490 adults aged 18 to 80 who either know they carry the mutation or are from families with the mutation will receive eith…
Matched conditions: ALZHEIMERS DISEASE, FAMILIAL
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Could a new combo drug delay Alzheimer's in High-Risk families?
Disease control OngoingThis study tests whether an experimental drug (E2814) combined with lecanemab can slow Alzheimer's disease in people who carry a genetic mutation that causes it. About 197 adults aged 18-80 with mild or no symptoms will receive either the drug or a placebo for up to 4 years. Rese…
Matched conditions: ALZHEIMERS DISEASE, FAMILIAL
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:02 UTC